Skip to main content

Table 3 Percentage (%) distributions and odds ratios for receipt of conservative therapy (n = 3,328).

From: Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1)

Characteristic

%

Crude 1

OR (95% CI)

Adj.2

OR (95% CI)

Age at diagnosis

     

   <60

12.13

1.00

(referent)

1.00

(referent)

   60-64

17.96

1.59

(1.15 - 2.20)

1.65

(1.18 - 2.33)

   65-69

20.38

1.85

(1.37 - 2.52)

1.90

(1.38 - 2.63)

   70-74

32.58

3.50

(2.63 - 4.71)

3.35

(2.46 - 4.59)

   75-79

46.71

6.35

(4.70 - 8.67)

6.76

(4.87 - 9.47)

   >= 80

82.49

34.13

(23.00 - 51.68)

27.09

(17.66 - 42.31)

Race/ethnicity

     

   Non-Hispanic White

27.59

1.00

(referent)

1.00

(referent)

   Non-Hispanic Black

37.85

1.60

(1.30 - 1.96)

1.65

(1.28 - 2.13)

   Non-Hispanic Other

33.93

1.35

(0.76 - 2.33)

1.28

(0.66 - 2.40)

   Hispanic

35.96

1.47

(0.99 - 2.17)

1.56

(0.98 - 2.45)

   Unknown

36.36

1.50

(0.60 - 3.52)

1.02

(0.31 - 3.02)

Marital status

     

   Married

25.16

1.00

(referent)

1.00

(referent)

   Not Married

42.81

2.23

(1.86 - 2.67)

1.72

(1.39 - 2.14)

   Unknown

42.22

2.17

(1.59 - 2.96)

1.70

(1.15 - 2.49)

Insurance

     

   Private/other

26.03

1.00

(referent)

1.00

(referent)

   None

30.77

1.26

(0.52 - 2.83)

2.31

(0.89 - 5.52)

   Public

40.18

1.91

(1.58 - 2.31)

1.51

(1.20 - 1.89)

   Unknown

38.98

1.82

(1.39 - 2.37)

1.60

(1.14 - 2.25)

Registry

     

   California

31.56

1.00

(referent)

1.00

(referent)

   Colorado

27.50

0.82

(0.63 - 1.08)

1.37

(0.99 - 1.90)

   Illinois

32.38

1.04

(0.80 - 1.35)

0.95

(0.68 - 1.32)

   Louisiana

31.13

0.98

(0.75 - 1.28)

0.59

(0.42 - 0.82)

   New York

26.07

0.77

(0.58 - 1.01)

0.85

(0.60 - 1.20)

   Rhode Island

29.31

0.90

(0.68 - 1.18)

1.12

(0.80 - 1.56)

   South Carolina

27.07

0.81

(0.60 - 1.09)

0.63

(0.43 - 0.91)

Screen-detected

     

   Yes

22.60

1.00

(referent)

1.00

(referent)

   No

43.17

2.60

(2.20 - 3.08)

2.32

(1.86 - 2.91)

   Unknown

36.87

2.00

(1.57 - 2.53)

1.47

(1.08 - 1.99)

DRE results

     

   Normal

29.42

1.00

(referent)

1.00

(referent)

   Abnormal

24.40

0.77

(0.65 - 0.93)

0.67

(0.54 - 0.84)

   Equivocal/unknown

35.48

1.32

(1.10 - 1.58)

0.91

(0.73 - 1.15)

PSA value

     

   0-4

27.59

1.00

(referent)

1.00

(referent)

   >4-10

20.15

0.66

(0.50 - 0.88)

0.69

(0.50 - 0.97)

   >10-20

29.01

1.07

(0.79 - 1.47)

0.80

(0.56 - 1.15)

   >20-50

45.38

2.18

(1.53 - 3.12)

1.41

(0.93 - 2.15)

   50+

52.25

2.87

(1.83 - 4.53)

1.73

(1.02 - 2.94)

   Unknown

49.89

2.61

(1.91 - 3.60)

1.64

(1.12 - 2.41)

Gleason score

     

   2-4

45.17

1.00

(referent)

1.00

(referent)

   5-7

25.05

0.41

(0.32 - 0.51)

0.45

(0.34 - 0.59)

   8-10

34.26

0.63

(0.46 - 0.87)

0.49

(0.33 - 0.72)

   Unknown

48.58

1.15

(0.88 - 1.61)

0.75

(0.50 - 1.13)

Comorbidity score

     

   0

26.91

1.00

(referent)

1.00

(referent)

   1

39.00

1.74

(1.41 - 2.14)

1.44

(1.12 - 1.86)

   2+

54.78

3.29

(2.26 - 4.81)

2.59

(1.67 - 4.03)

  1. 1: OR = odds ratio; CI = confidence interval.
  2. 2: Adjusted for factors shown in the table.